Kedrion Biopharma and InstaLILY to Host Healthcare AI Innovation Summit at NY Tech Week
Kedrion Biopharma and InstaLILY will co-host the Rare Connections: Healthcare AI Innovation Summit on June 3 as part of NY Tech Week, announced in a press release. The invitation-only event will gather leaders from the pharmaceutical, technology, investment, and research sectors to explore how organizations are implementing artificial intelligence across healthcare.
The half-day summit will include sessions on clinical development, commercial operations, specialty pharmacies, investment strategy, and responsible technology adoption. Discussions will focus on how AI is being used to improve decision making, patient access, and healthcare outcomes.
Speakers will include representatives from Google DeepMind, Bain Capital Private Equity, Kedrion Biopharma, InstaLILY AI, Insight Partners, and other organizations. The event aims to highlight practical examples of AI adoption that enhance operational efficiency and patient experiences.
The summit will take place on June 3 in New York during NY Tech Week. Interested participants can request to join the waitlist through the event website.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Nov 13 Bracco and Avicenna.AI win FDA clearance for AI that flags brain aneurysms on CT scans Nov 13 Zus Health raises $33 million to build the data layer for healthcare AI Nov 13 Google DeepMind releases AlphaGenome 2 to predict DNA variant effects in specific cell types Nov 13 Taiwan hospital accelerator T+ MedIC names AI ECG and CT screening tools as first winners Nov 13 Sheinbaum meets OpenAI president Greg Brockman on AI in Mexican healthcareLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Industry analysis
2025 Global Business Services Agenda: Gen AI Takes Center Stage
This industry analysis by The Hackett Group explores the transformative impact of generative artificial intelligence (Gen AI) on global business services (GBS) in 2025. The study highlights the shift from exploration to acceleration of Gen AI initiatives, with 89% of executives advancing these projects to improve customer satisfaction, innovate products, and reduce costs. The report also discusses the challenges and strategies for successful Gen AI adoption, emphasizing the need for a technology-enabled operating model and the importance of reskilling the workforce.
Read moreYou may also like
The AI Summit New York Returns to the Javits Center on December 9 and 10
STPI Hosts AI Healthcare Conclave at IIT BHU
Kipu Health Plans ELEVATE 2027 AI Preview for May
New York Launches State AI Safety Testing Center and Opens RAISE Act Registration for Frontier AI Developers
Likang to Present AI Cancer Immunotherapy Platform in Abu Dhabi
Daily AI Brief: the AI news that matters, in your inbox.